The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Arginase inhibition mediates cardioprotection during ischaemia–reperfusion
Abstract
AIMS: Nitric oxide (NO) is vital for the integrity of the cardiovascular system and protection against ischaemic heart disease. Arginase is up-regulated during ischaemia-reperfusion (IR) and this enzyme might compete with NO synthase (NOS) for arginine. The present study investigated whether arginase blockade protects from myocardial IR injury and whether such an effect is coupled to increased NO bioavailability. METHODS AND RESULTS: Sprague-Dawley rats were subjected to 30 min of coronary artery ligation, followed by 2 h of reperfusion. The animals were given either saline, or the arginase inhibitor N-omega-hydroxy-nor-l-arginine (nor-NOHA) with or without the NO scavenger carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (cPTIO) or the NOS inhibitor N(G)-monomethyl-l-arginine (l-NMMA) iv 15 min before ischaemia. The infarct size was 79 +/- 4% of the area at risk in the control group. Nor-NOHA treatment reduced the infarct size to 39 +/- 7% (P < 0.001). Administration of cPTIO or l-NMMA completely abolished the protective effect of nor-NOHA. Expression of arginase I was significantly (P < 0.05) increased in ischaemic myocardium. Nor-NOHA treatment resulted in higher plasma levels of nitrite (P < 0.05) and a 10-fold increase in the citrulline/ornithine ratio (P < 0.001), indicating a shift in arginine utilization towards NOS. CONCLUSION: Inhibition of arginase protects from myocardial infarction by a mechanism that is dependent on NOS activity and bioavailability of NO by shifting arginine utilization from arginase towards NOS. These findings suggest that targeting of arginase is a promising future therapeutic strategy for protection against myocardial IR injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739
Lindroth, P., & Mopper, K. (1979) · Analytical Chemistry · doi:10.1021/ac50047a019 · Cited by 1,838
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver
Duranski, M. R., Greer, J. J. M., Dejam, A., Jaganmohan, S., Hogg, N., Langston, W., Patel, R. P., Yet, S.-F., Wang, X., Kevil, C. G., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22493 · Cited by 674
The emerging biology of the nitrite anion
Gladwin, M. T., Schechter, A. N., Kim-Shapiro, D. B., Patel, R. P., Hogg, N., Shiva, S., Cannon, R. O., Kelm, M., Wink, D. A., Espey, M. G., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio1105-308 · Cited by 609
Govoni, M., Jansson, E. Å., Weitzberg, E., & Lundberg, J. O. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.08.003 · Cited by 602
Self-citationARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION
Durante, W., Johnson, F. K., & Johnson, R. A. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04638.x · Cited by 577
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T. A., Lopez, B. L., Koch, W. J., Chan, L., Goldstein, B. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.666941 · Cited by 452
The ubiquitous role of nitric oxide in cardioprotection
Jones, S. P., & Bolli, R. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.09.011 · Cited by 434
Research works printed but not linked: 1
- 2005, Journal of Clinical Investigation, 115, 1232, 10.1172/JCI200522493 · DOI · Paper page
Cited by
Sorted by citations
Items 101–139 of 139
Tratsiakovich, Y., Kiss, A., Gonon, A. T., Yang, J., Sjöquist, P.-O. B., & Pernow, J. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116687935 · Cited by 13
Cheng, H., Lu, T., Wang, J., Xia, Y., Chai, X., Zhang, M., Yao, Y., Zhou, N., Zhou, S., Chen, X., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00201 · Cited by 13
Momma, T. Y., & Ottaviani, J. I. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.033 · Cited by 12
ANTARCTIC FISH METABOLIC RESPONSES AS POTENTIAL BIOMARKERS OF ENVIRONMENTAL IMPACT
Rodrigues, E., Suda, C. N. K., Rodrigues, E., de Oliveira, M. F., Carvalho, C. D. S., & Vani, G. S. (2011) · Oecologia Australis · doi:10.4257/oeco.2011.1501.10 · Cited by 12
Ebner, B., Lange, S. A., Eckert, T. C., Wischniowski, C., Ebner, A., Braun-Dullaeus, R. C., Weinbrenner, C., Wunderlich, C., Simonis, G., & Strasser, R. H. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1480-y · Cited by 11
Koo, B., Won, M., Kim, Y., & Ryoo, S. (2020) · Cells · doi:10.3390/cells9020392 · Cited by 11
Agunloye, O. M. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13490 · Cited by 9
On the metabolic origin of cancer: substances that target tumor metabolism
Israël, M., & Schwartz, L. H. (2011) · Biomedical Research-tokyo · Cited by 8
Metabolome analysis reveals a diversity of cancer tissues in advanced epithelial ovarian cancer
Yoshida, K., Yoshikawa, N., Kitami, K., Tamauchi, S., Ikeda, Y., Yokoi, A., Nishino, K., Niimi, K., & Kajiyama, H. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02014-7 · Cited by 8
Chen, Z., Kebschull, L., Föll, D., Rauen, U., Hansen, U. J., Heitplatz, B., Heßler, M., Senninger, N. J., Vogel, T., Mohr, A., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20191989 · Cited by 7
Eligini, S., Porro, B., Werba, J. P., Capra, N., Genovese, S., Greco, A., Cavalca, V., & Banfi, C. (2022) · Biomedicines · doi:10.3390/biomedicines10061407 · Cited by 6
Cell-autonomous and non-cell-autonomous effects of Arginase 2 on cardiac aging
Potenza, D. M., Cheng, X., Ajalbert, G., Brenna, A., Giraud, M., Frobert, A., Cook, S., Mertz, K. D., Yang, Z., & Ming, X. (2025) · eLife · doi:10.7554/elife.94794.3 · Cited by 5
Choi, K., Koo, B., Yoon, B., Jung, M., Yun, H., Jeon, B., Won, M., Kim, Y., Mun, J., Lim, H. K., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11307 · Cited by 5
Markova, E., Wolowczyk, C., Mohamed, A. F., Sofias, A. M., Martin‐Armas, M., Sundset, R., Berndtsson, J., Hak, S., & Škalko‐Basnet, N. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106959 · Cited by 5
Cell-autonomous and non-cell-autonomous effects of Arginase 2 on cardiac agingPreprint
Potenza, D. M., Cheng, X., Ajalbert, G., Brenna, A., Giraud, M., Frobert, A., Cook, S., Mertz, K. D., Yang, Z., & Ming, X. (2024) · eLife · doi:10.7554/elife.94794 · Cited by 4
Yi, B., Zhao, Y., Han, Y. Y., Li, Z., Zhang, P., Fang, Z., Zhao, Y., Yang, H., & Guo, N. (2024) · Journal of Chromatography A · doi:10.1016/j.chroma.2024.464732 · Cited by 3
Chen, X., Li, L., Ma, S., Ling, C., Lai, J., Yao, H., Guo, W., Yang, H. J., Zhang, Y., Lin, W., et al. (2025) · Biomarkers in Medicine · doi:10.1080/17520363.2025.2455924 · Cited by 3
Betge, S., KUNZ, C., Figulla, H. R., & Jung, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2003 · Cited by 3
Muessig, J. M., Moellhoff, L., Noelle, J., Kaya, S., Pareja, L. H., Masyuk, M., Roden, M., Kelm, M., & Jung, C. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.01.008 · Cited by 3
Cell-autonomous and non-cell-autonomous effects of arginase-II on cardiac agingPreprint
Potenza, D. M., Cheng, X., Ajalbert, G., Brenna, A., Giraud, M., Frobert, A., Cook, S., Mertz, K. D., Yang, Z., & Ming, X. (2024) · eLife · doi:10.7554/elife.94794.1 · Cited by 3
Arginase-II gene deficiency reduces skeletal muscle aging in mice
Caretti, M., Potenza, D. M., Ajalbert, G., Albrecht, U., Ming, X., Brenna, A., & Yang, Z. (2024) · Aging · doi:10.18632/aging.206173 · Cited by 2
Mołek, P., Żmudzki, P., Machnik, A., Nowak, G., Stępień, K., Wnuk, M., Włodarczyk, A., Nowak, K. W., Rychlak, R., Nessler, J. M., et al. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16356 · Cited by 2
MECHANISMS OF DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION AND PROSPECTS OF CORRECTION
Дзугкоев, С. Г. (2014) · CyberLeninK (CyberLeninka) · Cited by 2
Evaluation of ADS-33E Cargo Helicopter Requirements Using a CH-53G
Höfinger, M., Blanken, C. L., & Strecker, G. (2006) · Vertical Flight Society Forum · doi:10.4050/vfs-f62-085 · Cited by 2
The Role of FoxO4 in Post-Myocardial Infarction Left Ventricular Remodeling.
Liu, Z. (2016) · Cited by 1
Sobolev, M. S., Файтельсон, А. В., Гудырев, О. С., Raj, R. D. S., Дубровин, Г. М., & MYAGKIH, V. I. (2017) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2017-24-6-116-121 · Cited by 1
Arginase Activity as a Useful Cardiac Marker for Differential Diagnosis of UA and MI: A Pilot Study
Yerawar, C., Abhang, S. A., & Joshi, P. (2014) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2015/11870 · Cited by 1
Metabolome Analysis Reveals a Diversity of Cancer Tissues in Advanced Epithelial Ovarian CancerPreprint
Yoshida, K., Yoshikawa, N., Kitami, K., Tamauchi, S., Ikeda, Y., Yokoi, A., Nishino, K., Niimi, K., & Kajiyama, H. (2021) · Research Square · doi:10.21203/rs.3.rs-361726/v1 · Cited by 1
Zhang, M., Du, G., Xie, L., Xu, Y., & Chen, W. (2024) · eLife · doi:10.7554/elife.97267.1 · Cited by 1
Cell-autonomous and non-cell-autonomous effects of arginase-II on cardiac agingPreprint
Potenza, D. M., Cheng, X., Ajalbert, G., Brenna, A., Giraud, M., Frobert, A., Cook, S., Mertz, K. D., Yang, Z., & Ming, X. (2025) · eLife · doi:10.7554/elife.94794.2 · Cited by 1
Cardioprotection afforded by targeting guanylyl cyclase during early reperfusion
Bice, J. S. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Shemyakin, A. S., Kövamees, P. O., & Rafnsson, B. A. (2016)
Arginine, Tetrahydrobiopterin, and Nitric Oxide in Myocardial Protection
Velayutham, M., Druhan, L. J., & Cardounel, A. J. (2013) · CRC Press eBooks · doi:10.1201/b14663-10
Evaluation of Arginase and Nitric oxide levels in Sepsis
Mulgund, D. M. S. R., & Abhang, S. A. (2014) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2014.i04.11
Shen, L., Yang, D. S., Chen, R., & Liu, D. (2020) · Research Square · doi:10.21203/rs.3.rs-48911/v1
(2013) · Circulation · doi:10.1161/cir.0b013e3182967f47
The role of arginase in human health and disease
Costanzo, L. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00008-5
Zhang, M., Du, G., Xie, L., Xu, Y., & Chen, W. (2024) · eLife · doi:10.7554/elife.97267.2
Arginase in vascular disease: Mechanisms, measurement, and medicine
Durante, W. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.09.053
Metadata
- Authors
- Jung, C., Gonon, A. T., Sjoquist, P.-O., Lundberg, J. O., & Pernow, J.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Corresponding author
- Jung, C.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-02
- Volume
- 85
- Issue
- 1
- Pages
- 147-154
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2019788114
- Cited by
- 139
- References
- 35
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 11 · 2023: 1 · 2022: 7 · 2021: 6 · 2020: 16 · 2019: 3 · 2018: 8 · 2017: 6 · 2016: 6 · 2015: 10 · 2014: 17 · 2013: 16 · 2012: 8
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- arginase inhibition, myocardial ischemia-reperfusion injury, nitric oxide bioavailability, nitric oxide synthase, arginine utilization, nor-NOHA, cardioprotection, myocardial infarct size, nitrite, L-NMMA, cPTIO
- MeSH terms
- Amino Acids, Animals, Arginase, Arginine, Blood Pressure, Enzyme Inhibitors, Heart Rate, Male, Myocardial Infarction, Myocardium, Nitric Oxide, Nitrites, Myocardial Reperfusion Injury, Rats, Sprague-Dawley, Nitric Oxide Synthase, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
